Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in brain NE turnover after chronic DMI treatment; no effect with iprindole.

B N Rosloff, J M Daivis

    Psychopharmacology
    |April 11, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lack of effect of acute and chronic treatment with tricyclic antidepressants on rat brain choline acetyltransferase.

    Research communications in chemical pathology and pharmacology·1976
    Same author

    Effect of iprindole on norepinephrine turnover and transport.

    Psychopharmacologia·1974
    See all related articles

    Chronic antidepressant treatment impacts norepinephrine turnover. Desmethylimipramine (DMI) reduced turnover, suggesting a link to clinical effects, while iprindole did not, offering insights into antidepressant mechanisms.

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Biochemistry

    Background:

    • Tricyclic antidepressants (TCAs) are clinically effective for mood disorders.
    • Chronic TCA administration, not acute, correlates with therapeutic benefits.
    • The mechanism involves alterations in brain norepinephrine (NE) turnover.

    Purpose of the Study:

    • To investigate the effects of chronic desmethylimipramine (DMI) and iprindole on rat brain NE turnover.
    • To compare the impact of a potent NE reuptake blocker (DMI) with a non-reuptake blocker (iprindole).
    • To explore the relationship between NE turnover and the clinical efficacy of TCAs.

    Main Methods:

    • Chronic administration of DMI and iprindole to rats.
    • Measurement of rat brain NE turnover using the Conversion Index.

    Related Experiment Videos

  • Assessment of endogenous brain NE and tyrosine levels.

    • Main Results:

    • Chronic DMI treatment significantly decreased NE turnover.
    • Chronic iprindole treatment did not alter NE turnover.
    • Chronic DMI tended to decrease endogenous brain NE levels.
    • Both DMI and iprindole tended to decrease brain and plasma tyrosine levels.

    Conclusions:

    • Chronic DMI's effect on NE turnover supports its role in the therapeutic action of TCAs.
    • Iprindole's lack of effect on NE turnover suggests alternative mechanisms for its clinical efficacy.
    • Findings contribute to understanding the 'catecholamine hypothesis of affective disorders'.